According to a report by the Institute of Medicine (IOM), the National Cancer Institute’s (NCI) Clinical Trials Cooperative Group program was inefficient, underfunded, and filled with red tape. The NCI program contains 3,100 institutions in the U.S., Canada, and...
PharmaVOICE has featured Pearl Pathways twice in the last year. In January 2012, Pearl President and CEO, Diana Caldwell, shared her thoughts on the expansion of Pearl’s services to meet the growing needs of their customers. In April 2012, Chief Operating...
Please join us at the IHIF Annual Meeting from May 7-8. Pearl will be in attendance with 3-4 teammates so be sure to look for us! The topic of the event is: “Statewide Strategic Plan for the Health Sector”. To learn more and to register, click...
Please join us for a lively discussion directed by Jody Roth about “Key Regulatory Trends in 2011 Biological Approvals” at the next RAPS Indiana Chapter event. The event will be held on May 14th, 2012 from 4:00pm-6:00pm at the IUETC Ice Miller Room. To...
Pearl is excited to announce its release of several case studies. Check out our case study section to see how Pearl offers real solutions to companies ranging from small start-ups to large multi-nationals. To view our IRB case studes, click here. To see the breadth...
